biosimilar biological product development meeting
Defined in 1 place of the United States Code.
The term “biosimilar biological product development meeting” means any meeting, other than a biosimilar initial advisory meeting, regarding the content of a development program, including a proposed design for, or data from, a study intended to support a biosimilar biological product application.
Source
- 2012–present21 U.S.C. § 379j-51Food and Drugs · Definitions · for purposes of this subpart